Cargando…
COVID-19 and systemic sclerosis: analysis of lifestyle changes during the SARS-CoV-2 pandemic in an Italian single-center cohort
The outbreak of SARS-CoV-2 has changed the habits and lives of people worldwide. Patients affected by systemic sclerosis (SSc) experienced constant fear because of their immunocompromised status. The aim of this study was to investigate the prevalence of SARS-CoV-2 infection and to analyze the lifes...
Autores principales: | Pellegrino, Greta, Mohammad Reza Beigi, Davide, Angelelli, Carlotta, Stefanantoni, Katia, Cadar, Marius, Mancuso, Silvia, Conti, Fabrizio, Riccieri, Valeria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666573/ https://www.ncbi.nlm.nih.gov/pubmed/33188620 http://dx.doi.org/10.1007/s10067-020-05504-7 |
Ejemplares similares
-
Psychological Fragility in an Italian Cohort of Systemic Sclerosis Patients During COVID-19 Pandemic Category: Short Communication
por: Mohammad Reza Beigi, Davide, et al.
Publicado: (2022) -
Heparin-Independent and Heparin-Dependent Anti-CXCL4 Antibodies Have a Reciprocal Expression in a Systemic Sclerosis Patients’ Cohort
por: Palazzo, Raffaella, et al.
Publicado: (2022) -
New Autoantibody Specificities in Systemic Sclerosis and Very Early Systemic Sclerosis
por: Lande, Roberto, et al.
Publicado: (2021) -
CXCL4-RNA Complexes Circulate in Systemic Sclerosis and Amplify Inflammatory/Pro-Fibrotic Responses by Myeloid Dendritic Cells
por: Pietraforte, Immacolata, et al.
Publicado: (2022) -
The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis
por: Colasanti, Tania, et al.
Publicado: (2022)